Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Diagnosis of Sarcoidosis

Diagnosis of Sarcoidosis Abstract • During the last decade, many biochemical and immunologic advances have been made in the treatment and understanding of sarcoidosis. These studies have helped us to understand the basic mechanisms involved in granuloma formation, and many clinicians have used the information to diagnose and assess the activity of sarcoidosis. Further studies are needed to clearly establish the role of these advances in the everyday management of patients with sarcoidosis. (Arch Intern Med 1983;143:1418-1419) References 1. Sharma OP: Diagnosis of sarcoidosis. Arch Intern Med 1978;138:689-690.Crossref 2. Siltzbach LE: Qualities and behaviour of satisfactory Kveim suspensions. Ann NY Acad Sci 1976;278:665-668.Crossref 3. Israel HL, Goldstein RA: Relation of Kveim-antigen reaction to lymphadenopathy. N Engl J Med 1976;284:488-497. 4. Lieberman J: The specificity and nature of serum angiotensin—converting enzyme (SACE) elevations in sarcoidosis. Am J Med 1976;59: 365-378.Crossref 5. Silverstein E, Friedland J, Lyons HA, et al: Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: Clinical and possible pathogenic significance. Ann NY Acad Sci 1976;278: 498-513.Crossref 6. Abboy R, Kanada DJ, Sharma OP: Serum angiotensin-converting enzyme in sarcoidosis , in Williams WJ, Davies BH (eds): Sarcoidosis and Other Granulomatous Diseases . London, Alpha Omega Publishing, 1980, pp 273-276. 7. Siltzbach LE, Krakoff L, Dorph D, et al: Elevated levels of serum angiotensin—converting enzyme and lysozyme levels in sarcoidosis , in William WJ, Davies BH (eds): Sarcoidosis and Other Granulomatous Diseases . London, Alpha Omega Publishing, 1980, pp 298-302. 8. Selroos 0: Serum lysozyme in sarcoidosis: Evaluation of its usefulness in determination of disease activity. Scand J Resp Dis 1977;58:110-116. 9. Gilbert HS, Siltzbach LE: Increased levels of circulating transcobalamin II in sarcoidosis , in Williams WJ, Davies BH (eds): Sarcoidosis and Other Granulomatous Diseases . London, Alpha Omega Publishing, 1980, pp 485-490. 10. Beaumont D, Herry JY, Sapene M, et al: Gallium-67 in the evaluation of sarcoidosis: Correlations with serum angiotensin—converting enzyme and bronchoalveolar lavage. Thorax 1982;37:11-18.Crossref 11. Crystal RG, Roberts WC, Hunninghake GW, et al: Pulmonary sarcoidosis: A disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 1981;94:73-94.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Diagnosis of Sarcoidosis

Archives of Internal Medicine , Volume 143 (7) – Jul 1, 1983

Loading next page...
 
/lp/american-medical-association/diagnosis-of-sarcoidosis-PWlET5rXBz
Publisher
American Medical Association
Copyright
Copyright © 1983 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1983.00350070138021
Publisher site
See Article on Publisher Site

Abstract

Abstract • During the last decade, many biochemical and immunologic advances have been made in the treatment and understanding of sarcoidosis. These studies have helped us to understand the basic mechanisms involved in granuloma formation, and many clinicians have used the information to diagnose and assess the activity of sarcoidosis. Further studies are needed to clearly establish the role of these advances in the everyday management of patients with sarcoidosis. (Arch Intern Med 1983;143:1418-1419) References 1. Sharma OP: Diagnosis of sarcoidosis. Arch Intern Med 1978;138:689-690.Crossref 2. Siltzbach LE: Qualities and behaviour of satisfactory Kveim suspensions. Ann NY Acad Sci 1976;278:665-668.Crossref 3. Israel HL, Goldstein RA: Relation of Kveim-antigen reaction to lymphadenopathy. N Engl J Med 1976;284:488-497. 4. Lieberman J: The specificity and nature of serum angiotensin—converting enzyme (SACE) elevations in sarcoidosis. Am J Med 1976;59: 365-378.Crossref 5. Silverstein E, Friedland J, Lyons HA, et al: Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: Clinical and possible pathogenic significance. Ann NY Acad Sci 1976;278: 498-513.Crossref 6. Abboy R, Kanada DJ, Sharma OP: Serum angiotensin-converting enzyme in sarcoidosis , in Williams WJ, Davies BH (eds): Sarcoidosis and Other Granulomatous Diseases . London, Alpha Omega Publishing, 1980, pp 273-276. 7. Siltzbach LE, Krakoff L, Dorph D, et al: Elevated levels of serum angiotensin—converting enzyme and lysozyme levels in sarcoidosis , in William WJ, Davies BH (eds): Sarcoidosis and Other Granulomatous Diseases . London, Alpha Omega Publishing, 1980, pp 298-302. 8. Selroos 0: Serum lysozyme in sarcoidosis: Evaluation of its usefulness in determination of disease activity. Scand J Resp Dis 1977;58:110-116. 9. Gilbert HS, Siltzbach LE: Increased levels of circulating transcobalamin II in sarcoidosis , in Williams WJ, Davies BH (eds): Sarcoidosis and Other Granulomatous Diseases . London, Alpha Omega Publishing, 1980, pp 485-490. 10. Beaumont D, Herry JY, Sapene M, et al: Gallium-67 in the evaluation of sarcoidosis: Correlations with serum angiotensin—converting enzyme and bronchoalveolar lavage. Thorax 1982;37:11-18.Crossref 11. Crystal RG, Roberts WC, Hunninghake GW, et al: Pulmonary sarcoidosis: A disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 1981;94:73-94.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Jul 1, 1983

References